BALANCED SALT
Clinical safety rating
cautionComprehensive clinical and safety monograph for BALANCED SALT (BALANCED SALT).
Balanced salt solutions are used for irrigation and replacement of extracellular fluid. They provide essential ions (sodium, potassium, calcium, magnesium, chloride, bicarbonate) to maintain osmotic balance and pH homeostasis. The mechanism involves restoration of electrolyte composition and fluid volume without direct pharmacological activity.
| Metabolism | Not metabolized; components are directly excreted or incorporated into physiological pools. Excess ions are eliminated via renal excretion. |
| Excretion | Renal: >95% of electrolytes and water eliminated unchanged via kidneys (glomerular filtration and tubular reabsorption dynamics); biliary/fecal: <5% |
| Half-life | Not applicable; components (sodium, chloride, potassium, calcium, magnesium, acetate, citrate) are endogenous and rapidly equilibrated; clinical context: no terminal elimination half-life as they are physiologic substances |
| Protein binding | Minimal to none; electrolytes are free in solution; no significant binding to plasma proteins (e.g., albumin, globulins) |
| Volume of Distribution | Approximately 0.2 L/kg (extracellular fluid volume); clinically indicates distribution primarily into interstitial and intravascular spaces |
| Bioavailability | Intravenous: 100%; ophthalmic: Not applicable (topical administration delivers directly to site, systemic absorption negligible) |
| Onset of Action | Intravenous: Immediate (seconds to minutes) upon infusion for electrolyte and fluid correction; ophthalmic: Within minutes for corneal hydration and pH buffering |
| Duration of Action | Intravenous: Duration depends on infusion rate and renal function; typically minutes to hours for electrolyte effects; ophthalmic: Several minutes (transient) before dilution by tears |
| Molecular Weight | Not applicable (mixture of salts); individual molecular weights: NaCl 58.44, KCl 74.55, CaCl2·2H2O 147.01, MgCl2·6H2O 203.30, NaC3H5O3 (sodium lactate) 112.06. |
Intraocular irrigation during surgery: sufficient volume to maintain anterior chamber depth. Also used as IV fluid: 500-1000 mL bolus, then 50-100 mL/hour continuous infusion for volume replacement.
| Dosage form | SOLUTION |
| Renal impairment | No dose adjustment required for intraocular use. For IV use, caution in severe renal impairment (eGFR <30 mL/min) with monitoring for electrolyte imbalances; consider reducing infusion rate. |
| Liver impairment | No adjustment required for either route; balanced salt solution is not hepatically metabolized. |
| Pediatric use | Intraocular: as per surgeon's discretion. IV: weight-based, 10-20 mL/kg bolus then 2-5 mL/kg/hour continuous infusion for volume depletion. |
| Geriatric use | No specific dose adjustment; monitor for fluid overload and electrolyte disturbances, especially in patients with cardiac or renal compromise. |
| 1st trimester | Balanced salt solution is generally considered safe when used as an intravenous electrolyte replenisher; no known teratogenic effects. |
| 2nd trimester | Safe for maternal hydration and electrolyte balance; use only as clinically indicated. |
| 3rd trimester | Safe for use near term for hydration; monitor for fluid overload in preeclampsia or renal impairment. |
Clinical note
Comprehensive clinical and safety monograph for BALANCED SALT (BALANCED SALT).
| Placental transfer | Electrolytes freely cross the placenta; balanced salt solution does not contain drugs or additives that would cause concern. |
| Breastfeeding | Balanced salt solution components (sodium, chloride, potassium, calcium, magnesium) are normal constituents of breast milk; no adverse effects expected with maternal IV administration. |
| Lactation Rating | Safe |
| Teratogenic Risk | No evidence of teratogenic risk; considered safe during all trimesters when used as directed (topical ophthalmic). |
| Fetal Monitoring | No specific monitoring required beyond standard prenatal care. |
| Fertility Effects | No known effects on fertility. |
■ FDA Black Box Warning
None.
| Serious Effects |
None when used as an isotonic electrolyte solution; avoid in patients with severe hypernatremia, hyperkalemia, or heart failure with fluid overload without careful monitoring.
| Precautions | Hypersensitivity reactions may occur, Use with caution in patients with renal impairment due to risk of electrolyte overload, Monitor serum electrolytes and fluid balance during prolonged use, Do not use if solution is discolored or contains particulate matter |
| Food/Dietary | No known food interactions. Maintain normal hydration unless otherwise instructed. |
| Clinical Pearls | Use a sterile technique for intraocular irrigation. Avoid prolonged corneal exposure. Discard unused solution immediately. Monitor intraocular pressure post-procedure. |
| Patient Advice | Report any eye pain, redness, or vision changes immediately. · Do not touch the dropper tip to any surface. · Use as directed by your surgeon. · Discard bottle after single use. |
Loading safety data…